Derivatives of 2-(2-phenylethyl) chromone have been shown to mitigate the expression of CD36 in macrophages mediated by endoplasmic reticulum stress, thereby inhibiting the formation of foam cells and exerting a therapeutic effect on atherosclerosis (Chen L. et al., 2022). The gene discussed is CD36; the disease is atherosclerosis.